TRANSESOPHAGEAL ECHOCARDIOGRAPHICALLY FACILITATED EARLY CARDIOVERSION FROM ATRIAL-FIBRILLATION USING SHORT-TERM ANTICOAGULATION - FINAL RESULTS OF A PROSPECTIVE 4.5-YEAR STUDY

被引:259
作者
MANNING, WJ
SILVERMAN, DI
KEIGHLEY, CS
OETTGEN, P
DOUGLAS, PS
机构
[1] BETH ISRAEL HOSP, CHARLES A DANA RES INST, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, BOSTON, MA USA
[3] JOHN DEMPSEY HOSP, DIV CARDIOL, FARMINGTON, CT USA
[4] UNIV CONNECTICUT, CTR HLTH, FARMINGTON, CT USA
关键词
D O I
10.1016/0735-1097(94)00560-D
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. We sought to validate the safety of transesophageal echocardiographically guided early cardioversion in conjunction with short-term anticoagulation as a strategy for guiding early cardioversion in hospitalized patients with atrial fibrillation. Background. Because atrial thrombi are poorly seen by conventional imaging techniques, several weeks of prophylactic anticoagulation is routinely prescribed before cardioversion. Transesophageal echocardiography is a superior test for identifying atrial thrombi; preliminary feasibility studies have supported its use to guide early cardioversion for patients in whom no thrombus is observed, but safety has not been validated in any large series. Methods. All patients admitted to hospital with atrial fibrilla tion during a 4.5-year period were screened. The inclusion criterion was a clinical duration of atrial fibrillation >2 days or of unknown duration. Patients received anticoagulation with heparin/warfarin and underwent conventional transthoracic echocardiography followed by transesophageal study. Patients in whom transesophageal echocardiography revealed no atrial thrombus underwent pharmacologic or electrical cardioversion followed by warfarin therapy for 1 month. Cardioversion was deferred in patients with evidence of atrial thrombi, and they received prolonged warfarin treatment. Results. Two hundred thirty-three patients (86% of those eligible) agreed to participate, and 230 underwent transesophageal echocardiography. Transesophageal echocardiography identified 40 atrial thrombi (left atrium 34, right atrium 6) in 34 patients (15%). One hundred eighty six (95%) of 196 patients without thrombi had successful cardioversion to sinus rhythm, all without prolonged anticoagulation, and none (0%, 95% confidence interval 0% to 1.6%) experienced a clinical thromboembolic event. Eighteen patients with atrial thrombi underwent uneventful cardioversion after prolonged anticoagulation. Conclusions. Compared with smaller series that have shown only feasibility, this large prospective and consecutive study of patients undergoing transesophageal echocardiographically facilitated early cardioversion in conjunction with short-term anticoagulation validates the safety of this strategy. This treatment algorithm has a safety profile similar to conventional therapy and minimizes both the period of anticoagulation and the overall duration of atrial fibrillation.
引用
收藏
页码:1354 / 1361
页数:8
相关论文
共 52 条
[1]  
ANDERSON DC, 1992, ANN INTERN MED, V116, P6
[2]   ROLE OF PROPHYLACTIC ANTICOAGULATION FOR DIRECT-CURRENT CARDIOVERSION IN PATIENTS WITH ATRIAL-FIBRILLATION OR ATRIAL-FLUTTER [J].
ARNOLD, AZ ;
MICK, MJ ;
MAZUREK, RP ;
LOOP, FD ;
TROHMAN, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (04) :851-855
[3]   TRANSESOPHAGEAL TWO-DIMENSIONAL ECHOCARDIOGRAPHY FOR THE DETECTION OF LEFT ATRIAL APPENDAGE THROMBUS [J].
ASCHENBERG, W ;
SCHLUTER, M ;
KREMER, P ;
SCHRODER, E ;
SIGLOW, V ;
BLEIFELD, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (01) :163-166
[4]   EFFICACY OF ANTICOAGULANT THERAPY IN PREVENTING EMBOLISM RELATED TO DC ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION [J].
BJERKELUND, CJ ;
ORNING, OM .
AMERICAN JOURNAL OF CARDIOLOGY, 1969, 23 (02) :208-+
[5]   EVALUATION OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY BEFORE CARDIOVERSION OF ATRIAL-FIBRILLATION AND FLUTTER IN NONANTICOAGULATED PATIENTS [J].
BLACK, IW ;
HOPKINS, AP ;
LEE, LCL ;
WALSH, WF .
AMERICAN HEART JOURNAL, 1993, 126 (02) :375-381
[6]   EXCLUSION OF ATRIAL THROMBUS BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY DOES NOT PRECLUDE EMBOLISM AFTER CARDIOVERSION OF ATRIAL-FIBRILLATION - A MULTICENTER STUDY [J].
BLACK, IW ;
FATKIN, D ;
SAGAR, KB ;
KHANDHERIA, BK ;
LEUNG, DY ;
GALLOWAY, JM ;
FENELEY, MP ;
WALSH, WF ;
GRIMM, RA ;
STOLLBERGER, C ;
VERHORST, PMJ ;
KLEIN, AL .
CIRCULATION, 1994, 89 (06) :2509-2513
[7]   MITRAL REGURGITATION ASSOCIATED WITH REDUCED THROMBOEMBOLIC EVENTS IN HIGH-RISK PATIENTS WITH NONRHEUMATIC ATRIAL-FIBRILLATION [J].
BLACKSHEAR, JL ;
PEARCE, LA ;
ASINGER, RW ;
DITTRICH, HC ;
GOLDMAN, ME ;
ZABALGOITIA, M ;
ROTHBART, RM ;
HALPERIN, JL .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 72 (11) :840-843
[8]   PREVALENCE AND CLINICAL IMPLICATIONS OF ATRIAL SPONTANEOUS CONTRAST IN PATIENTS UNDERGOING TRANSESOPHAGEAL ECHOCARDIOGRAPHY [J].
CASTELLO, R ;
PEARSON, AC ;
LABOVITZ, AJ .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (16) :1149-1153
[9]   HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT THERAPY [J].
COON, WW ;
WILLIS, PW .
ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (03) :386-392
[10]   PREVENTION OF BACTERIAL-ENDOCARDITIS - RECOMMENDATIONS BY THE AMERICAN-HEART-ASSOCIATION [J].
DAJANI, AS ;
BISNO, AL ;
CHUNG, KJ ;
DURACK, DT ;
FREED, M ;
GERBER, MA ;
KARCHMER, AW ;
MILLARD, HD ;
RAHIMTOOLA, S ;
SHULMAN, ST ;
WATANAKUNAKORN, C ;
TAUBERT, KA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (22) :2919-2922